Mark Plavsic - 14 Jun 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role: Chief Technical Officer
Signature: /s/ Cindy R. Tahl, as Attorney-in-Fact
Issuer symbol: FATE
Transactions as of: 14 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 22 Jun 2021, 16:03:49 UTC
Next filing: 22 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FATE	Common Stock	Award	$0	+38,000		$0.000000	38,000	14 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FATE	Stock Option (Right to Buy)	Award	$0	+18,500		$0.000000	18,500	14 Jun 2021	Common Stock	18,500	$89.97	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Exempt grant of restricted stock units pursuant to the Issuer's Inducement Equity Plan. The units will vest in four annual installments after July 1, 2021, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.
F2	The option shall vest as to 25% of the underlying shares on June 14, 2022 and thereafter on a monthly basis for 36 additional months, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.